Investing in the Future of Toxicology: The Rise of Non-Animal Testing Models - AInvest

Retrieved on: 2025-09-01 19:23:51

Tags for this article:

Drug discovery

Animal testing

Laboratory techniques

Bioethics

Clinical research

Alternatives to animal testing

Preclinical development

Food and Drug Administration

Investigational New Drug

Animal disease model

Drug development

Toxicology

Click the tags to see associated articles and topics

Investing in the Future of Toxicology: The Rise of Non-Animal Testing Models - AInvest. View article details on hiswai:

Excerpt

The U.S. Food and Drug Administration (FDA) has taken a decisive step by phasing out mandatory animal testing for monoclonal antibody therapies, a ...

Article found on: www.ainvest.com

View Original Article